Interaction Guide · Research summary

Can I take Atropa Belladonna with Imipramine?

Review Atropa Belladonna with Imipramine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Avoid adding an active belladonna preparation to imipramine without prescriber review. Both can contribute anticholinergic effects, while the actual belladonna formulation determines exposure.

What this answer covers

Atropa belladonna products with active alkaloid exposure; whole plant, concentrated extracts and highly diluted products are not equivalent.

Supplement or preparation
Atropa belladonna
Medication ingredient
imipramine

Why the medicine warning matters

Imipramine has anticholinergic effects and its label calls for careful supervision with anticholinergic agents. Added effects may involve vision, urination, bowel function or mental clarity.

The plant itself can be toxic

A belladonna berry-ingestion case caused visual changes, dilated pupils, disorientation and agitation. This establishes an active-plant hazard, not the amount of risk from every product with belladonna on its label.

Confirm whether active alkaloids are present

Bring the exact product, dilution, plant part and dose for review. Do not assume raw plant, tincture and highly diluted products have the same exposure.

Recognize symptoms that need prompt care

New confusion, severe blurred vision, inability to urinate or significant abdominal distention needs urgent assessment, particularly after a new active belladonna product. Do not try to correct the problem by changing imipramine yourself.

Evidence and practical considerations

Side effects & toxicity

Conditional anticholinergic precaution is supported by exact imipramine warning and original plant-toxicity evidence; no quantified exact-pair risk.

Exact scope
Atropa belladonna products with active alkaloid exposure; whole plant, concentrated extracts and highly diluted products are not equivalent. with Exact oral imipramine hydrochloride tablets. RxNorm IN 5691/PIN 150816 hydrochloride; pamoate capsule is not assumed the same tested formulation. Desipramine metabolite evidence is distinguished from directly prescribed imipramine.
Medication form and route
oral
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • Plant poisoning report did not involve imipramine; ingredient name alone does not establish alkaloid dose.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral imipramine.

Exact label warns about anticholinergic and sympathomimetic co-use, alcohol-related CNS effects and MAOI combinations. It does not explicitly name tryptophan, St John’s wort or serotonin syndrome.

How this applies: RxNorm IN 5691/PIN 150816 hydrochloride; pamoate capsule is not assumed the same tested formulation. Desipramine metabolite evidence is distinguished from directly prescribed imipramine.

No universal supplement interval, event rate or preparation equivalence established. Original label distinguishes warnings from measured pair-specific results.

Source 2: original case report

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: One adult presenting after accidental berry ingestion.

Visual disturbance, dilated pupils, disorientation, loss of balance, agitation and anxiety were consistent with anticholinergic intoxication.

How this applies: Only the named drug, preparation, route and measured endpoints apply.

No imipramine and no supplement-extract assay; intrinsic plant poisoning does not quantify combination risk.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.
Research summary published

Article revision: 620a73c2b0bd0c50

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.